These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12692373)

  • 1. Treatment of bullous pemphigoid.
    Fontaine J; Joly P; Roujeau JC
    J Dermatol; 2003 Feb; 30(2):83-90. PubMed ID: 12692373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of topical corticosteroids in bullous pemphigoid in the elderly.
    Joly P; Fontaine J; Roujeau JC
    Drugs Aging; 2005; 22(7):571-6. PubMed ID: 16038572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bullous pemphigoid: a review].
    Bernard P; Charneux J
    Ann Dermatol Venereol; 2011 Mar; 138(3):173-81. PubMed ID: 21397147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interventions for bullous pemphigoid.
    Kirtschig G; Middleton P; Bennett C; Murrell DF; Wojnarowska F; Khumalo NP
    Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD002292. PubMed ID: 20927731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
    Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
    N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetracycline, nicotinamide, and lesionally administered clobetasol as a therapeutic option to prednisone in patients with bullous pemphigoid: a comparative, retrospective analysis of 106 patients with long-term follow-up.
    Kalinska-Bienias A; Kowalczyk E; Jagielski P; Kowalewski C; Wozniak K
    Int J Dermatol; 2019 Feb; 58(2):172-177. PubMed ID: 30350359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prospective study of treatment of bullous pemphigoid by a class I topical corticosteroid].
    Zimmermann R; Faure M; Claudy A
    Ann Dermatol Venereol; 1999 Jan; 126(1):13-6. PubMed ID: 10095883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of bullous pemphigoid: recommendations for immunomodulatory treatments.
    Kirtschig G; Khumalo NP
    Am J Clin Dermatol; 2004; 5(5):319-26. PubMed ID: 15554733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pemphigoid gestationis: treatment by topical class I corticosteroid].
    Valeyrie L; Lebrun-Vignes B; Bodak N; Grossin M; Descamps V; Crickx B; Bélaïch S
    Ann Dermatol Venereol; 2001 May; 128(5):638-40. PubMed ID: 11427799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole body application of a potent topical corticosteroid for bullous pemphigoid.
    Terra JB; Potze WJ; Jonkman MF
    J Eur Acad Dermatol Venereol; 2014 Jun; 28(6):712-8. PubMed ID: 23551654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of bullous pemphigoid with dapsone, methylprednisolone, and topical clobetasol propionate: a retrospective study of 62 cases.
    Schmidt E; Kraensel R; Goebeler M; Sinkgraven R; Bröcker EB; Rzany B; Zillikens D
    Cutis; 2005 Sep; 76(3):205-9. PubMed ID: 16268266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2003; (3):CD002292. PubMed ID: 12917929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of 16 patients with bullous pemphigoid with oral tetracycline and niacinamide and topical clobetasol.
    Hornschuh B; Hamm H; Wever S; Hashimoto T; Schröder U; Bröcker EB; Zillikens D
    J Am Acad Dermatol; 1997 Jan; 36(1):101-3. PubMed ID: 8996271
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of bullous pemphigoid with topical clobetasol propionate.
    Westerhof W
    J Am Acad Dermatol; 1989 Mar; 20(3):458-61. PubMed ID: 2645323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for bullous pemphigoid.
    Khumalo N; Kirtschig G; Middleton P; Hollis S; Wojnarowska F; Murrell D
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002292. PubMed ID: 16034874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Replacing systemic with topical corticotherapy in patients with generalized bullous pemphigoid and serious steroid-induced iatrogenesis].
    García-Doval I; Conde A; Mayo E; Cruces MJ
    Actas Dermosifiliogr; 2006 Apr; 97(3):186-8. PubMed ID: 16796965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of pemphigus and pemphigoids.
    López-Jornet P; Bermejo-Fenoll A
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):410-1. PubMed ID: 16264376
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids.
    Muramatsu T; Iida T; Shirai T
    J Dermatol; 1996 Oct; 23(10):683-8. PubMed ID: 8973033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the safety and efficacy of a potent topical cortico-steroid in the treatment of bullous pemphigoid.
    Claudy A
    Clin Dermatol; 2001; 19(6):778-80. PubMed ID: 11705688
    [No Abstract]   [Full Text] [Related]  

  • 20. Bullous pemphigoid treated by topical corticosteroids.
    Paquet P; Richelle M; Lapiere CM
    Acta Derm Venereol; 1991; 71(6):534-5. PubMed ID: 1685838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.